US Patent 11596545 Systems and methods for ocular drug delivery
Patent 11596545 was granted and assigned to Clearside Biomedical on March, 2023 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
November 1, 2018
Date of Patent
March 7, 2023
Patent Applicant
Patent Application Number
16178162
Patent Citations
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11596545 Systems and methods for ocular drug delivery
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.